133 related articles for article (PubMed ID: 1512549)
1. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome.
Molina IJ; Kenney DM; Rosen FS; Remold-O'Donnell E
J Exp Med; 1992 Sep; 176(3):867-74. PubMed ID: 1512549
[TBL] [Abstract][Full Text] [Related]
2. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.
Molina IJ; Sancho J; Terhorst C; Rosen FS; Remold-O'Donnell E
J Immunol; 1993 Oct; 151(8):4383-90. PubMed ID: 8409409
[TBL] [Abstract][Full Text] [Related]
3. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation.
Gallego MD; Santamaría M; Peña J; Molina IJ
Blood; 1997 Oct; 90(8):3089-97. PubMed ID: 9376590
[TBL] [Abstract][Full Text] [Related]
4. Decreased alpha/beta heterodimer among CD8 molecules of peripheral blood T cells in Wiskott-Aldrich syndrome.
Kawabata K; Nagasawa M; Morio T; Okawa H; Yata J
Clin Immunol Immunopathol; 1996 Nov; 81(2):129-35. PubMed ID: 8906743
[TBL] [Abstract][Full Text] [Related]
5. Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome.
Gerwin N; Friedrich C; Perez-Atayde A; Rosen FS; Gutierrez-Ramos JC
Clin Exp Immunol; 1996 Nov; 106(2):208-17. PubMed ID: 8918565
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
[TBL] [Abstract][Full Text] [Related]
7. Sialophorin (CD43) and the Wiskott-Aldrich syndrome.
Remold-O'Donnell E; Rosen FS
Immunodefic Rev; 1990; 2(2):151-74. PubMed ID: 2223062
[TBL] [Abstract][Full Text] [Related]
8. CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytes.
Dragone L; Pallant A; Insel R; Frelinger JG
Exp Clin Immunogenet; 1992; 9(3):130-40. PubMed ID: 1338889
[TBL] [Abstract][Full Text] [Related]
9. Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome.
Siminovitch KA; Greer WL; Axelsson B; Rubin LA; Novogrodsky A; Peacocke M
Immunodeficiency; 1993; 4(1-4):99-108. PubMed ID: 8167744
[TBL] [Abstract][Full Text] [Related]
10. Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome.
Khan S; Holding S; Doré PC; Sewell WA
Med Hypotheses; 2008; 70(2):269-72. PubMed ID: 17664047
[TBL] [Abstract][Full Text] [Related]
11. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
12. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.
Park JY; Kob M; Prodeus AP; Rosen FS; Shcherbina A; Remold-O'Donnell E
Clin Exp Immunol; 2004 Apr; 136(1):104-10. PubMed ID: 15030520
[TBL] [Abstract][Full Text] [Related]
13. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
Rosenstein Y; Park JK; Hahn WC; Rosen FS; Bierer BE; Burakoff SJ
Nature; 1991 Nov; 354(6350):233-5. PubMed ID: 1683685
[TBL] [Abstract][Full Text] [Related]
14. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.
Piller F; Le Deist F; Weinberg KI; Parkman R; Fukuda M
J Exp Med; 1991 Jun; 173(6):1501-10. PubMed ID: 2033371
[TBL] [Abstract][Full Text] [Related]
15. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.
Kenney D; Cairns L; Remold-O'Donnell E; Peterson J; Rosen FS; Parkman R
Blood; 1986 Dec; 68(6):1329-32. PubMed ID: 3779101
[TBL] [Abstract][Full Text] [Related]
16. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome.
Higgins EA; Siminovitch KA; Zhuang DL; Brockhausen I; Dennis JW
J Biol Chem; 1991 Apr; 266(10):6280-90. PubMed ID: 2007580
[TBL] [Abstract][Full Text] [Related]
17. Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects.
Laskowski TJ; Van Caeneghem Y; Pourebrahim R; Ma C; Ni Z; Garate Z; Crane AM; Li XS; Liao W; Gonzalez-Garay M; Segovia JC; Paschon DE; Rebar EJ; Holmes MC; Kaufman D; Vandekerckhove B; Davis BR
Stem Cell Reports; 2016 Aug; 7(2):139-48. PubMed ID: 27396937
[TBL] [Abstract][Full Text] [Related]
18. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.
Mentzer SJ; Remold-O'Donnell E; Crimmins MA; Bierer BE; Rosen FS; Burakoff SJ
J Exp Med; 1987 May; 165(5):1383-92. PubMed ID: 3572301
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
Altman LC; Snyderman R; Blaese RM
J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
[TBL] [Abstract][Full Text] [Related]
20. Effect of platelet calpain on normal T-lymphocyte CD43: hypothesis of events in the Wiskott-Aldrich syndrome.
Remold-O'Donnell E; Van Brocklyn J; Kenney DM
Blood; 1992 Apr; 79(7):1754-62. PubMed ID: 1558970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
